Tatva Chintan Pharma Chem Limited has informed the Exchange about Copy of Newspaper Publication
TATVA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Tatva Chintan Pharma Chem has informed BSE and NSE that it published the extract of its unaudited financial results for the quarter ended 30 June 2025 in two newspapers on 25 July 2025. The publication appeared in the Financial Express (English edition) and Vadodara Samachar (Gujarati edition). The filing was made under Regulation 30 and 47 of SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. Company Secretary Ishwar Nayi signed the letter and noted that the same information is also available on the company's website (www.tatvachintan.com). No specific financial numbers are disclosed in this filing — it only confirms that the mandatory newspaper publication has been carried out as per compliance rules.
This is a routine regulatory compliance filing with no direct impact on the stock price. Investors should look at the actual Q1 FY26 results extract (published in the newspapers or on the company website) for any meaningful performance data.